Connective tissue activation. xxxvi. the origin, variety, distribution, and biologic fate of connective tissue activating peptide–iii isoforms: characteristics in patients with rheumatic, renal, and arterial disease-Reference-Cited by-同舟云学术

Connective tissue activation. xxxvi. the origin, variety, distribution, and biologic fate of connective tissue activating peptide–iii isoforms: characteristics in patients with rheumatic, renal, and arterial disease

Published:1993-09 Issue:8 Volume:36 Page:1142-1153
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Castor C. W.,Andrews P. C.,Swartz R. D.,Ellis S. G.,Hossler P. A.,Clark M. R.,Matteson E. L.,Sachter E. F.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference47 articles.

1. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.

2. Complete covalent structure of human .beta.-thromboglobulin

3. Cloning of cDNA coding for connective tissue activating peptide III from a human platelet-derived lambda gt11 expression library

4. The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4

5. Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How post-translational modifications influence the biological activity of chemokines;Cytokine;2018-09

2. Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis;Annals of the Rheumatic Diseases;2015-04-09

3. Chemokines and their receptors in rheumatoid arthritis: Future targets?;Arthritis & Rheumatism;2005

4. Constitutive and regulated expression of platelet basic protein in human monocytes;Journal of Leukocyte Biology;2003-12-12

5. Chemokines and chemokine receptors in rheumatoid arthritis;Seminars in Immunology;2003-02